Neuralink & Emerging Brain-Computer Interface: How Brain-Computer Interfaces are Shaping Technology, Healthcare & Ethics

Abstract

The rapidly expanding field of study of Brain-Computer Interfaces (BCIs), which resides on the changes that technologies like Neuralink are bringing and how they can change healthcare, communication, and the human mind. BCIs facilitate the creation of close interaction between the human brain and external equipment, which eradicates traditional neuromuscular processes. BCIs were first conceptualised in the 1960s and have evolved into less invasive technologies like Electroencephalography (EEG), and also more invasive technologies in which implanted electrodes are employed. Neuralink, which was founded by Elon Musk, has been on the frontline to help push the boundaries of BCI technology, which it has done by creating ultra-thin, flexible electrodes that are designed to create as minimal damage as possible to the tissues. The company will not only be interested in treating certain medical conditions, like paralysis, neurodegenerative diseases; it will also aim at enhancing cognitive abilities of human beings like memory and learning. The challenge now comes with numerical values in that invasive (i.e. implantable) BCIs, like those developed by Neuralink, have a far higher signal precision (up to 5,000 channels of brain activity) than non-invasive methods like EEG, which has lower signal capture and lower resolution. Research has also revealed that though non-invasive systems, such as BrainGate have already been proven to be workable in the context of motor rehabilitation in small-scale studies, additional research is required to find out long-term feasibility and also to find out the applicability of these systems across a broad array of patients. Still, there are some significant legal, health, and technical issues, which arise and become more profound as BCIs deepen. Medical concerns are health matters like how implanted devices affect the brain tissue in the long run, their biocompatibility, and immune rejection. The moral implications are even more profound as it is related to the domain of privacy, consent, or even potential misuse of neural information. This is because, as BCIs open the door to cognitive improvements, the problems of social equity and autonomy are raised, as well as access to such technologies. The paper offers a juxtaposition of the technology of Neuralink against the system of non-invasive technology (BrainGate and EEG) and their technical performance, medical application, and ethical concerns that arise regarding the same. It also provides an outline of responsible development and implementation of BCIs, stating the need to introduce new policies to safeguard individual privacy and provide equitable access to the life-altering technologies.